Last mentioned: 9h ago
Operational Launch
The new facilities are expected to come online and begin API production.
Construction Start
Anticipated groundbreaking for the two new manufacturing plants.
Manufacturing Expansion
AbbVie announces $380 million investment for North Chicago API facilities.
FedEx Files Suit
FedEx officially files suit in the U.S. Court of International Trade for a full refund.
Supreme Court Ruling
U.S. Supreme Court rules the administration's use of IEEPA for these tariffs was unlawful.
$100B Pledge
AbbVie commits to $100 billion in U.S. R&D and capital investments over the next decade.
Profit Warning
FedEx warns investors of a potential $1 billion profit impact from trade policies.
Tariffs Imposed
Trump administration imposes sweeping global tariffs using IEEPA authority.
The Trump administration has initiated a formal investigation into the trade practices of several nations, with India identified as a primary target. The probe focuses on alleged unfair trade practices, signaling a potential shift toward new tariffs that could disrupt global supply chain diversification efforts.
AbbVie has announced a $380 million investment to expand active pharmaceutical ingredient (API) manufacturing in North Chicago, marking the first major step in a $100 billion decade-long commitment to U.S. R&D and production. The move aligns with federal efforts to reshore critical drug supply chains and lower costs through direct-to-patient channels like TrumpRx.
FedEx has filed a landmark lawsuit against the Trump administration, seeking a full refund of tariff payments following a Supreme Court ruling that declared the use of the International Emergency Economic Powers Act (IEEPA) unlawful. As the first major corporation to seek restitution, FedEx's move signals the beginning of a massive legal wave that could see billions of dollars in duties returned to U.S. importers.